Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

This study has been completed.
Information provided by (Responsible Party):
CTI BioPharma Identifier:
First received: July 28, 2004
Last updated: May 20, 2013
Last verified: May 2013